News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
252,001 Results
Type
Article (6406)
Company Profile (24)
Press Release (245571)
Multimedia
Podcasts (2)
Webinars (4)
Section
Business (87510)
Career Advice (469)
Deals (16413)
Drug Delivery (8)
Drug Development (21430)
Employer Resources (30)
FDA (4347)
Job Trends (4313)
News (130428)
Policy (8667)
Tag
2027 Genetown Elite (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (2)
Academia (307)
Accelerated approval (6)
Adcomms (4)
Allergies (14)
Alliances (16502)
ALS (38)
Alzheimer's disease (302)
Antibody-drug conjugate (ADC) (46)
Approvals (4466)
Artificial intelligence (83)
Autoimmune disease (28)
Automation (5)
Bankruptcy (104)
Best Places to Work (3052)
Biosimilars (33)
Biotechnology (23)
Bladder cancer (34)
Brain cancer (8)
Breast cancer (104)
Cancer (946)
Cardiovascular disease (70)
Career advice (400)
Career pathing (3)
CAR-T (64)
CDC (2)
Cell therapy (167)
Cervical cancer (5)
Clinical research (18820)
Collaboration (379)
Compensation (384)
Complete response letters (8)
COVID-19 (333)
CRISPR (13)
C-suite (357)
Cystic fibrosis (29)
Data (1439)
Denatured (1)
Depression (28)
Diabetes (104)
Diagnostics (2210)
Digital health (8)
Diversity (1)
Diversity, equity & inclusion (13)
Drug discovery (31)
Drug pricing (14)
Drug shortages (2)
Duchenne muscular dystrophy (35)
Earnings (44707)
Editorial (5)
Employer branding (6)
Employer resources (32)
Events (41223)
Executive appointments (446)
FDA (5148)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (358)
Gene editing (24)
Generative AI (6)
Gene therapy (106)
GLP-1 (153)
Government (462)
Guidances (205)
Healthcare (5251)
HIV (19)
Huntington's disease (5)
IgA nephropathy (11)
Immunology and inflammation (40)
Immuno-oncology (7)
Indications (21)
Infectious disease (364)
Inflammatory bowel disease (37)
Inflation Reduction Act (3)
Influenza (7)
Intellectual property (35)
Interviews (53)
IPO (8208)
IRA (3)
Job creations (1345)
Job search strategy (366)
JPM (4)
Kidney cancer (10)
Labor market (10)
Layoffs (115)
Leadership (5)
Legal (2738)
Liver cancer (22)
Longevity (2)
Lung cancer (100)
Lymphoma (71)
Machine learning (3)
Management (10)
Manufacturing (151)
MASH (51)
Medical device (4164)
Medtech (4176)
Mergers & acquisitions (8631)
Metabolic disorders (246)
Multiple sclerosis (19)
NASH (6)
Neurodegenerative disease (54)
Neuropsychiatric disorders (16)
Neuroscience (566)
NextGen: Class of 2026 (1728)
Non-profit (745)
Now hiring (6)
Obesity (89)
Opinion (33)
Ovarian cancer (29)
Pain (26)
Pancreatic cancer (39)
Parkinson's disease (51)
Partnered (6)
Patents (57)
Patient recruitment (103)
Peanut (6)
People (26733)
Pharmaceutical (7)
Pharmacy benefit managers (2)
Phase 1 (5472)
Phase 2 (7998)
Phase 3 (6691)
Pipeline (2063)
Policy (17)
Postmarket research (834)
Preclinical (2092)
Press Release (66)
Prostate cancer (59)
Psychedelics (3)
Radiopharmaceuticals (113)
Rare diseases (184)
Real estate (2024)
Recruiting (8)
Regulatory (6323)
Reports (18)
Research institute (335)
Resumes & cover letters (69)
Rett syndrome (19)
RNA editing (1)
RSV (6)
Schizophrenia (52)
Series A (55)
Series B (55)
Sickle cell disease (10)
Special edition (1)
Spinal muscular atrophy (34)
Sponsored (5)
Startups (1108)
Stomach cancer (1)
Supply chain (15)
Tariffs (7)
The Weekly (1)
Vaccines (92)
Venture capital (9)
Weight loss (29)
Women's health (6)
Date
Last 7 days (155)
Last 30 days (539)
Last 365 days (9351)
2026 (822)
2025 (9526)
2024 (11674)
2023 (13931)
2022 (20385)
2021 (21246)
2020 (19729)
2019 (14249)
2018 (11009)
2017 (11221)
2016 (10365)
2015 (13654)
2014 (10706)
2013 (8455)
2012 (9082)
2011 (9476)
2010 (9338)
Location
Africa (197)
Alabama (20)
Alaska (2)
Arizona (74)
Arkansas (2)
Asia (12436)
Australia (1781)
California (3622)
Canada (1154)
China (171)
Colorado (144)
Connecticut (162)
Delaware (73)
Europe (36985)
Florida (554)
Georgia (67)
Idaho (24)
Illinois (170)
India (19)
Indiana (107)
Iowa (10)
Japan (168)
Kansas (37)
Kentucky (17)
Louisiana (8)
Maine (51)
Maryland (377)
Massachusetts (2935)
Michigan (104)
Minnesota (203)
Mississippi (1)
Missouri (34)
Montana (17)
Nebraska (13)
Nevada (47)
New Hampshire (16)
New Jersey (1031)
New Mexico (5)
New York (852)
North Carolina (516)
North Dakota (4)
Northern California (1888)
Ohio (119)
Oklahoma (5)
Oregon (7)
Pennsylvania (661)
Puerto Rico (1)
Rhode Island (19)
South America (306)
South Carolina (17)
Southern California (1348)
Tennessee (62)
Texas (486)
United States (12774)
Utah (113)
Virginia (114)
Washington D.C. (17)
Washington State (303)
West Virginia (2)
Wisconsin (57)
Wyoming (1)
252,001 Results for "amarin corporation plc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Amarin Announces Preliminary 2025 Financial Highlights and Operational Accomplishments, Including Achieving Positive Cash Flow; Company Well Positioned to Capture Global Growth Opportunities
January 8, 2026
·
11 min read
Press Releases
Amarin Reports Third Quarter 2025 Financial Results
October 29, 2025
·
17 min read
Press Releases
Amarin Applauds Breakthroughs In Therapies For Patients With Elevated Triglycerides; Company’s VASCEPA®/VAZKEPA® (Icosapent Ethyl) Franchise Well Positioned To Benefit Globally From Broadened Category Commercialization
January 9, 2026
·
13 min read
Press Releases
Amarin to Report Third Quarter 2025 Financial Results and Host Conference Call on October 29, 2025
October 16, 2025
·
2 min read
Press Releases
Amarin and HLS Therapeutics Collaborate on Presenting REDUCE-IT® and EPA Mechanistic Data at the Canadian Cardiovascular Congress
October 15, 2025
·
9 min read
Pharm Country
Amarin Board of Directors Announces CEO Transition
Amarin Corporation plc today announced that the Company’s Board of Directors has appointed Aaron Berg, currently Amarin’s Executive Vice President and President of the U.S. Business, as President and Chief Executive Officer (CEO).
June 4, 2024
·
5 min read
Press Releases
Amarin Issues Statement Supporting FDA’s Action to Revise Labeling for Fenofibrate Drugs Reinforcing a Lack of Cardiovascular Benefit
October 28, 2025
·
11 min read
Press Releases
HLS Therapeutics and Amarin Collaborate on Presenting REDUCE-IT® and EPA Mechanistic Data at the Canadian Cardiovascular Congress
October 15, 2025
·
4 min read
Press Releases
Amarin To Present New Analyses Affirming Robustness of Data from REDUCE-IT and Additional Mechanisms of Action of Eicosapentaenoic Acid (EPA) at American Heart Association (AHA) Scientific Sessions 2025
November 4, 2025
·
8 min read
Pharm Country
Amarin Announces Results of Annual General Meeting of Shareholders
Amarin Corporation plc announced shareholder approval of all proposed resolutions specified at its 2024 Annual General Meeting.
April 22, 2024
·
5 min read
1 of 25,201
Next
